Literature DB >> 1672915

Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix.

S B Pinion1, J H Kennedy, R W Miller, A B MacLean.   

Abstract

Expression of the oncogenes Ha-RAS, c-MYC, and ERB-2 was investigated with an automated image analysis system in 12 specimens of normal cervix, 10 of cervical intraepithelial neoplasia (CIN) grade 1, 24 of CIN 3, and 10 of invasive cancer of the cervix. There was amplification of all three oncogenes in CIN 3 and invasive cancer compared with normal cervix and CIN 1. The difference was most pronounced with an antibody to the RAS p21 protein, with no overlap between CIN 3 and the normal range. This method might be useful in screening for cervical neoplasia, and for the determination of which CIN lesions require treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672915     DOI: 10.1016/0140-6736(91)92518-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Abnormal cervical smear test results: old dilemmas and new directions.

Authors:  C Wilkinson
Journal:  Br J Gen Pract       Date:  1992-08       Impact factor: 5.386

2.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

3.  Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk.

Authors:  Sabrina Zidi; Mouna Stayoussef; Bano L Alsaleh; Ezzedine Gazouani; Amel Mezlini; Bashayer H Ebrahim; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2016-11-14       Impact factor: 3.201

4.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable?

Authors:  Chi Van Dang; Steven B McMahon
Journal:  Genes Cancer       Date:  2010-06

Review 5.  A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer.

Authors:  Emmanuel N Kontomanolis; Antonios Koutras; Zacharias Fasoulakis; Athanasios Syllaios; Michail Diakosavvas; Kyveli Angelou; Panagiotis Symeonidis; Athina A Samara; Vasilios Pergialiotis; Nikolaos Garmpis; Dimitrios Schizas; Athanasios Pagkalos; Athanasios Chionis; Georgios Daskalakis; Thomas Ntounis
Journal:  Cancer Diagn Progn       Date:  2022-03-03

6.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; J H Smith; S V Polacarz; K Rogers; F Sharp
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23

8.  Nucleolar organiser regions (AgNORS) in anal intraepithelial neoplasia and invasive anal squamous cell carcinoma.

Authors:  O A Ogunbiyi; J H Scholefield; F Sharp; R Ginsberg; K Rogers
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

9.  C-myc oncogene expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; K Rogers; F Sharp; J H Smith; S V Polacarz
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

10.  Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia.

Authors:  S K Jonas; C Benedetto; A Flatman; R H Hammond; L Micheletti; C Riley; P A Riley; D J Spargo; M Zonca; T F Slater
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.